---
title: "CRO concept stocks opened lower, SC Pharmaceuticals and Sinobioway Medicine hit the daily limit down"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237744997.md"
description: "CRO concept stocks opened lower, SC Pharmaceuticals and Sinobioway Medicine hit the daily limit down, while Boji Pharmaceutical, Hongbo Pharmaceutical, and Haofan Biotechnology all opened lower"
datetime: "2025-04-28T01:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237744997.md)
  - [en](https://longbridge.com/en/news/237744997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237744997.md)
---

# CRO concept stocks opened lower, SC Pharmaceuticals and Sinobioway Medicine hit the daily limit down

CRO concept stocks opened lower, SC Pharmaceuticals and Sinobioway Medicine hit the daily limit down, while Boji Pharmaceutical, Hongbo Pharmaceutical, and Haofan Biotechnology all opened lower

### Related Stocks

- [002581.CN](https://longbridge.com/en/quote/002581.CN.md)
- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)
- [301393.CN](https://longbridge.com/en/quote/301393.CN.md)
- [300404.CN](https://longbridge.com/en/quote/300404.CN.md)
- [301230.CN](https://longbridge.com/en/quote/301230.CN.md)

## Related News & Research

- [China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025](https://longbridge.com/en/news/290539713.md)
- [French mid-sized firms adopt AI but see few gains, survey shows](https://longbridge.com/en/news/290570224.md)
- [Lundbeck reports Phase IIb PROCEED trial data for anti-PACAP migraine drug bocunebart at EAN 2026](https://longbridge.com/en/news/290655422.md)
- [Priceline survey shows 79% of Americans plan summer trip despite rising travel costs](https://longbridge.com/en/news/290548980.md)
- [Shandong Xinhua Pharma wins China approval to start LXH-2103 pain drug clinical trials](https://longbridge.com/en/news/290406287.md)